Filaggrin (FLG) mutations drive susceptibility to AD through impairment of the skin barrier, promoting the penetration of external allergens, and releasing thymic stromal lymphopoietin (TSLP) (Furue et al., 2017; Meledathu et al., 2025). This evidence concerns the gene TSLP and Alzheimer disease.